Will Section IV of the 25th Amendment be used during Trump's Presidency?

**Stage 1 — Blind analysis (ignore market prices):**

The 25th Amendment's Section 4 has never been invoked in U.S. history and was designed for extreme, demonstrable presidential incapacity. Procedurally, Section 4 requires the Vice President plus a majority of the Cabinet to declare the President unable to discharge the powers and duties of the office. If the President disputes that declaration, Congress must convene and a two-thirds vote in both the House and Senate is required to sustain the declaration; otherwise the President regains the office. These are very high legal and political bars.

Given current facts (July 14, 2026):

- There is increased public conversation about Trump’s cognitive state sparked by public gaffes and a widely noted NATO speech. Prominent individuals and organizations are calling for invocation. That raises political pressure and makes Section 4 a live public topic. - However, Vice President JD Vance is the practical gatekeeper. All credible accounts indicate no active movement within the VP’s office or the Cabinet to initiate Section 4. Vance is politically aligned with Trump and lacks a clear institutional incentive to start an unprecedented process absent indisputable evidence. - The congressional safeguard (two-thirds of both chambers) makes successful, permanent removal extremely unlikely even if VP and Cabinet act. A contested invocation would need extraordinary bipartisan consensus that currently does not exist. - The most realistic trigger for Section 4 is an acute, objectively incapacitating medical event (stroke, severe neurological event, coma) or clear evidence that the President cannot perform duties and cannot or will not yield voluntarily. Political disagreements, incompetence in public speech, or impeachment-level misconduct are poor substitutes for the clinical/functional incapacity Section 4 contemplates.

Balancing these facts: the longer the term (through January 20, 2029), the more opportunity for a rare triggering event to occur. Still, given the VP gatekeeping, Cabinet incentives to avoid institutional rupture, and the requirement of extraordinary congressional votes if contested, I judge baseline odds that Section 4 will be used during the presidency at roughly **15%**. This reflects a small tail risk: non-zero because acute medical or neurological incapacity can happen, larger than zero because national institutions may feel compelled to act in extreme circumstances, but substantially constrained by the procedural and political barriers.

**Stage 2 — Market calibration (compare to current market: Yes 26% / No 74%):**

The current market price (Yes 26%) is materially above my independent estimate. Possible reasons the market is richer than my assessment:

- *Overweighting salience and media noise:* Markets can overreact to intense public conversation, high-profile calls for action, and viral gaffes. Vocal advocacy by celebrities, governors, or organizations increases perceived probability among traders even if procedural barriers remain high. - *Misinterpretation of “used”:* Some traders may be pricing the chance of any formal attempt, an initial Cabinet letter, or a highly publicized push (short of formal, sustained invocation) as a positive resolution, while the market instrument likely pays only if Section 4 is formally invoked per its legal standards. This conflation can inflate price. - *Tail hedging and event-specific books:* Traders who view the presidency as highly volatile may overpay to hedge very low-probability catastrophic scenarios (e.g., sudden incapacitation), bidding the price up relative to a neutral expected probability. - *Asymmetric information or concentrated order flow:* Large, well-informed traders may be taking positions based on private conversations or inside signals (unlikely but possible). High volume (148k contracts) means this market has liquidity and room for momentum trades that can push prices above fair value.

Why I think the market is mispricing upward:

- The institutional and political constraints (VP gatekeeper; Cabinet incentives; two-thirds congressional threshold) are concrete and historically durable. Media attention increases perceived risk but does not change the mechanics. - The most plausible pathway (acute medical incapacity) is rare. Markets may overweight anecdotal, incremental indicators of cognitive decline while underweighting the rarity of an acute incapacitating medical event.

Therefore, I view the market's 26% as an overstate of the true probability by perhaps a factor of ~1.7 (26% vs. my 15%). That suggests an arbitrage angle for traders who believe institutional constraints and legal mechanics dominate rhetorical pressure. However, if new evidence emerges that VP Vance or an increasing number of Cabinet members are preparing formal steps, the market's higher price would be justified and my estimate should be revised upward.

Additional calibration notes and caveats:

- My 15% already incorporates the extended timeframe to Jan 20, 2029; a shorter resolution window (e.g., by Dec 31, 2026) would meaningfully lower the probability. - I separate the probability of a formal, successful Congressional confirmation of incapacity (far lower) from the probability of Section 4 being *initiated*. If the market pays on initiation, its price should be higher than my estimate of full success — clarify the contract definition before trading. - If VP Vance’s political calculus changes (public admission of concern, private medical evidence disclosed, or defection within the Cabinet), the probability would jump sharply and justify higher market prices.